The role of monoclonal antibodies in the treatment of severe asthma
A number of therapeutic agents are available for the treatment of asthma, including inhaled corticosteroids, long- and short-acting beta-agonists, leukotriene-modifying agents, long- and short-acting anticholinergic agents, chromones, theophylline, allergen immunotherapy, and oral corticosteroid the...
Main Authors: | Louanne M. Tourangeau, Arthur Kavanaugh, Stephen I. Wasserman |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-06-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/1753465811400489 |
Similar Items
-
Role of Monoclonal Antibodies in the Treatment of Asthma
by: Paul M O’Byrne
Published: (2013-01-01) -
Dual Monoclonal Antibody Therapy for a Severe Asthma Patient
by: Christian Domingo, et al.
Published: (2020-09-01) -
The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review
by: Andrea Matucci, et al.
Published: (2018-08-01) -
Impact of prior smoking exposure and COPD comorbidity on treatment response to monoclonal antibodies in patients with severe asthma
by: Heba Morobeid, et al.
Published: (2021-08-01) -
Monoclonal Antibodies Targeting Alarmins: A New Perspective for Biological Therapies of Severe Asthma
by: Corrado Pelaia, et al.
Published: (2021-08-01)